IP Library Granted Patent US 11,279,912
Granted Patent B2
US 11,279,912 · App. 16/999,395 · Granted Mar 22, 2022

Cyanobacteria having improved photosynthetic activity

Inventors: James Roberts (Seattle, WA); Michael Carleton (Kirkland, WA); Damian Carrieri (Seattle, WA); Jason W. Hickman (San Diego, CA)
Assignee: LUMEN BIOSCIENCE, INC.
C12N1/20C07K14/195C12N1/125C12P7/64C12P7/6409C12P7/649C12P7/6436C12R2001/89Y02E50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,279,912
App. No.
16/999,395
Granted
Mar 22, 2022
Kind
B2
Abstract

This disclosure describes modified photosynthetic microorganisms, including Cyanobacteria, that have a reduced amount of a light harvesting protein (LHP) and contain one or more introduced or overexpressed polynucleotides encoding one or more enzymes associated with lipid biosynthesis, and which are capable of producing increased amounts of fatty acids and/or synthesizing triglycerides.

Claims (13)

1. A cell culture comprising a population of modified Cyanobacteria cells comprising genetic modifications including:

(a) an addition of an endogenous NbIA gene, addition of an exogenous NbIA gene, or addition of a promoter that regulates NbIA gene expression,

wherein the genetic modification results in changes that, as compared to corresponding wild-type Cyanobacteria, include:

an increased level of NbIA polypeptide or a biologically active fragment of NbIA polypeptide that includes a conserved domain,

an enhanced level of photosynthetic activity, and

a reduced amount of a light harvesting protein (LHP); and

(b) an addition of a nucleic acid sequence comprising an additional exogenous gene encoding an exogenous polypeptide.

2. The cell culture of claim 1 wherein the Cyanobacteria cell culture is cultured under light intensities between about

(a) 200 micromol photons per square meter per second, and

(b) 2000 micromol photons per square meter per second, and

wherein the genetically modified Cyanobacteria cell culture expresses the exogenous polypeptide.

3. The cell culture of claim 1 wherein the exogenous polypeptide is a therapeutic polypeptide.

4. The cell culture of claim 2 wherein the exogenous polypeptide is a therapeutic polypeptide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2021
From: ROBERTS, JAMES; HICKMAN, JASON W.; CARLETON, MICHAEL; CARRIERI, DAMIAN
To: MATRIX GENETICS, LLC
Reel/Frame 058430/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2021
From: MATRIX GENETICS, LLC
To: LUMEN BIOSCIENCE, INC.
Reel/Frame 058430/0134 →
Continuity (5)
Continuation 16791550 · Feb 14, 2020
Continuation 15879993 · Jan 25, 2018
Continuation 14775606
Provisional Application 61780755 · Mar 13, 2013
Related Publication 20210047610A1 · Feb 18, 2021
Cited By (3)
US 12,252,513 US 12,447,202 US 12,503,682